nitazoxanide has been researched along with Clostridioides difficile Infection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abed, M; Eid, PS; Elhusseiny, KM; Elkolaly, SS; Hashan, MR; Huu-Hoai, L; Huy, NT; Loc, LQ; Low, SK; Minh, LHN; Nghia, TLB; Tawfik, GM; Tieu, TM; Y, MN | 1 |
| Johnson, S; Soriano, MM | 1 |
| Bardin, MC; Sher, G; Yangco, BG | 1 |
| Dang, MD; DuPont, HL; Garey, KW; Hasbun, R; Jiang, ZD; Koo, HL; Shah, D | 1 |
| Baines, SD; Freeman, J; Huscroft, GS; Todhunter, SL; Wilcox, MH | 1 |
| Bookstaver, PB; Miller, AD; Musgrave, CR; Sutton, SS | 1 |
| Ballard, TE; Guerrant, RL; Hoffman, PS; Kennedy, A; Kolling, GL; Macdonald, TL; Olekhnovich, I; Riggins, M; van Opstal, E; Wang, X; Warren, CA; Warthan, M | 1 |
| Cheema, FH; Kanwal, S; Korsten, MA; Luthra, M; Majeed, UM; Rafiullah, F; Sohail, MR | 1 |
| Johnson, S; Venugopal, AA | 1 |
| Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA | 1 |
| Bouza, E; Burillo, A; Muñoz, P | 1 |
| Balagopal, A; Sears, CL | 1 |
7 review(s) available for nitazoxanide and Clostridioides difficile Infection
| Article | Year |
|---|---|
Effect of nitazoxanide on diarrhea: A systematic review and network meta-analysis of randomized controlled trials.
Topics: Animals; Clostridium Infections; Cryptosporidiosis; Diarrhea; Entamoebiasis; Giardia lamblia; Giardiasis; Humans; Network Meta-Analysis; Nitro Compounds; Thiazoles | 2020 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fidaxomicin; Humans; Microbial Sensitivity Tests; Nitro Compounds; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Thiazoles; Treatment Outcome | 2010 |
Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Immunotherapy; Nitro Compounds; Polymers; Probiotics; Thiazoles | 2011 |
Current state of Clostridium difficile treatment options.
Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
Antimicrobial therapy of Clostridium difficile-associated diarrhea.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Infant; Megacolon, Toxic; Metronidazole; Nitro Compounds; Risk Factors; Secondary Prevention; Thiazoles; Vancomycin | 2006 |
Clostridium difficile: new therapeutic options.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Depsipeptides; Diarrhea; Humans; Nitro Compounds; Polymers; Rifampin; Sulfonic Acids; Thiazoles | 2007 |
5 other study(ies) available for nitazoxanide and Clostridioides difficile Infection
| Article | Year |
|---|---|
Nitazoxanide and probiotics for the treatment of recurrent Clostridium difficile infection in a peritoneal dialysis patient.
Topics: Antiparasitic Agents; Clostridioides difficile; Clostridium Infections; Female; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Middle Aged; Nitro Compounds; Peritoneal Dialysis; Probiotics; Thiazoles | 2009 |
Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles | 2011 |
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzamides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enzyme Inhibitors; Fidaxomicin; Mice; Microbial Sensitivity Tests; Nitro Compounds; Pyruvate Synthase; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Metronidazole; Nitro Compounds; Recurrence; Thiazoles; Vancomycin | 2011 |
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin | 2013 |